An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients

NCT00666393 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Program Cancelled.

Conditions

Pain, Postoperative
Pediatrics

Interventions

DRUG: fentanyl iontophoretic transdermal system (40mcg) No placebo
DRUG: fentanyl iontophoretic transdermal system (40mcg)

Sponsor

Alza Corporation, DE, USA